Tylenol Shares Rise Despite Autism Risk Claim
Tylenol maker Kenvue’s stock rose in European trading on Tuesday, rebounding from a record low after US President Donald Trump linked its pain medication to autism risk during pregnancy. Analysts expect the recovery due to a lack of new evidence, but doctors reject the claim and Kenvue warned that such suggestions could harm maternal health. … Read more